Alector Inc (NASDAQ: ALEC) has experienced a rise in its stock price by 10.42 compared to its previous closing price of 1.44. However, the company has seen a gain of 7.43% in its stock price over the last five trading days. globenewswire.com reported 2025-06-03 that SOUTH SAN FRANCISCO, Calif., June 03, 2025 (GLOBE NEWSWIRE) — Alector, Inc. (Nasdaq: ALEC), a late-stage clinical biotechnology company focused on developing therapies to counteract the devastating progression of neurodegeneration, today announced that management will participate in a fireside chat at the Goldman Sachs 46th Annual Global Healthcare Conference on Tuesday, June 10, 2024, at 8:40 am ET.
Is It Worth Investing in Alector Inc (NASDAQ: ALEC) Right Now?
Moreover, the 36-month beta value for ALEC is 0.72. Analysts have varying opinions on the stock, with 5 analysts rating it as a “buy,” 1 as “overweight,” 1 as “hold,” and 1 as “sell.”
The public float for ALEC is 75.69M and currently, short sellers hold a 7.09% of that float. On June 11, 2025, ALEC’s average trading volume was 873.41K shares.
ALEC’s Market Performance
ALEC stock saw an increase of 7.43% in the past week, with a monthly gain of 35.90% and a quarterly increase of 13.57%. The volatility ratio for the week is 8.72%, and the volatility levels for the last 30 days are 6.71% for Alector Inc (ALEC). The simple moving average for the past 20 days is 19.03% for ALEC’s stock, with a -41.05% simple moving average for the past 200 days.
Analysts’ Opinion of ALEC
Many brokerage firms have already submitted their reports for ALEC stocks, with Mizuho repeating the rating for ALEC by listing it as a “Neutral.” The predicted price for ALEC in the upcoming period, according to Mizuho is $2.50 based on the research report published on December 17, 2024 of the previous year 2024.
Stifel, on the other hand, stated in their research note that they expect to see ALEC reach a price target of $4. The rating they have provided for ALEC stocks is “Hold” according to the report published on December 16th, 2024.
BofA Securities gave a rating of “Underperform” to ALEC, setting the target price at $1 in the report published on December 04th of the previous year.
ALEC Trading at 33.94% from the 50-Day Moving Average
After a stumble in the market that brought ALEC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -76.55% of loss for the given period.
#####
#####
Insider Trading
Reports are indicating that there were more than several insider trading activities at ALEC starting from GRASSO MARC, who sale 16,488 shares at the price of $1.34 back on Jun 02 ’25. After this action, GRASSO MARC now owns 296,072 shares of Alector Inc, valued at $22,068 using the latest closing price.
Kenkare-Mitra Sara, the President and Head of R&D of Alector Inc, sale 23,890 shares at $1.34 during a trade that took place back on Jun 02 ’25, which means that Kenkare-Mitra Sara is holding 512,252 shares at $31,974 based on the most recent closing price.
Stock Fundamentals for ALEC
Current profitability levels for the company are sitting at:
- -1.65 for the present operating margin
- 0.95 for the gross margin
The net margin for Alector Inc stands at -1.4. The total capital return value is set at -0.49. Equity return is now at value -90.26, with -23.65 for asset returns.
Based on Alector Inc (ALEC), the company’s capital structure generated 0.3 points at debt to capital in total, while cash flow to debt ratio is standing at -5.59.
Currently, EBITDA for the company is -136.16 million with net debt to EBITDA at -0.02. When we switch over and look at the enterprise to sales, we see a ratio of 1.83. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.34.
Conclusion
To wrap up, the performance of Alector Inc (ALEC) has been mixed in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.